NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Oberoi Realty Expands Mumbai Presence through Strategic Land Acquisitions

Oberoi Realty, a leading Indian real estate developer, is intensifying its focus on business development by securing strategic land acquisitions in Mumbai. A key development agreement was signed on Monday with the Maharashtra Housing and Area Development Authority (MHADA) for the redevelopment of Aram Nagar in Andheri West.

This strategic move marks a significant step in Oberoi Realty's expansion plans, underscoring its commitment to driving growth and innovation in the Indian real estate sector. The redevelopment of Aram Nagar is poised to bring new opportunities for residents, businesses, and the local community, contributing to the city's vibrant economic landscape.

Read also: Oshea Herbals Aims for Rs 650 Crore Revenue Amidst Expansion Efforts

Investor Takeaway

Investors should consider Oberoi Realty's strategic land acquisitions in Mumbai as a positive sign for its business growth.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.